제10회 서울국제신약포럼 > Forum & Conference

본문 바로가기

파이낸셜뉴스 부산파이낸셜뉴스 fn투어 fn아이포커스 fn아트


지난행사목록

본문

 

 Time

 Section Program

 08:00 ~ 09:00

 Registration

 Registration

 09:00 ~ 09:30

Opening

Ceremony

 <Opening Remark>

 Jeon, Jae Ho  Chairman & CEO, The Financial News

 <Congratulatory Remarks>

 Jeon, Hye Sook  Member, Health&Welfare Committee, 

                     National Assembly

 Ryu, Young Jin  Minister of Food and Drug Safety

 09:30 ~ 09:45

 Keynote Address

 Kim, Sung Soo  President, Korea Research Institute of Chemical 

                     Technology

 09:45 ~ 10:25

 Keynote Speech

 Patrick J. Casey  Professor, Duke University Medical Center

Session 1. Translational Research in Open Innovation

 10:25 ~ 10:45

Speech

 Kim, Young Hwa  Associate Director, AstraZeneca

 10:45 ~ 11:05

 Lee, Kwang Ho  Principal Investigator,

                     Korea Research Institute of Chemical Technology

 11:05 ~ 11:25

 Lee, Kyeong  Professor, College of Pharmacy, Dongguk University

 11:25 ~ 11:45

 Kim, Kyung Jin  President & CEO, ST PHARM

11:45 ~ 13:00    Luncheon 

Session 2. Convergence Technology beyond Drug Discovery

13:00 ~ 14:00

Panel

Discussion

 <Moderator>

 Han, Gyoon Hee  Dean, College of Pharmacy, Yonsei University

 <Panel>

 Kim, Joo Young  Manager, Health Industry Promotion Division,

                      Ministry of Health & Welfare

 Lee, Sung Joo  Founder, Orum Therapeutics

 Lee, Kwang Ho  Principal Investigator,

                     Korea Research Institute of Chemical Technology

 Hwang, Tae Ho  Director, MRC of PNU Medical School

14:00 ~ 14:30

Speech

 Cicero Nogueira Dos Santos  Research Staff Member, IBM Research

14:30 ~ 15:00

 Cho, Byoung Chul  Associate Professor, Yonsei Cancer Center

15:00 ~ 15:30

 Jeong, Jae Uk  Fellow & Scientific Leader, GSK

15:30 ~ 16:00

 Hwang, Tae Ho  Director, MRC of PNU Medical School

 

The program is subject to change


 

서울특별시 용산구 효창원로 154, 파이낸셜뉴스빌딩 3층 | TEL. 02-6965-0016 | FAX. 02-6965-0000 | E-mail : info@fnnews.com
Copyright 2017 The financial news. All rights reserved.